AntiCoagulation Europe (UK)

AntiCoagulation Europe (UK)

ABOUT US

Contact us

ANTIPLATELET THERAPY

Educational Films

News and developments Return to Archive >


Study identifies short haul DVT danger


Air travellers on journeys as short as three hours are at risk of deep vein thrombosis (DVT), latest research has shown.

Interim results of a new international study which has already examined more than 500 of a planned 900 passengers flying between the UK and Italy between May and September 2003 found blood clots in 4.3% of high-risk subjects after their flight.

Two passengers participating in the study went on to develop pulmonary embolisms possibly related to flights.

Travel-related DVT experts, led by Professor Gianni Belcaro of G D'Annunzio University in Italy, conducted the independent study. Passengers taking part were aged between 25 and 65 years old. They were screened with ultrasound for blood clots before and after their flight.

Professor Belcaro said: "The results show passengers are at risk of developing blood clots even on short flights - in fact, our research suggests most blood clots develop in the first two to three hours of a journey and grow larger and more dangerous with time.

"The problem can be worsened if travellers are then transferring straight to a car or coach for a long journey, or if they wait hours in airports.

"I recommend people making any kind of journey where they will be seated in cramped conditions should take a few simple precautions. These include taking plenty of exercise during the trip, drinking water and wearing flight socks to help the blood circulate and reduce the likelihood of clots developing.

"It is unusual to publish interim results, but we have taken the decision to publish them on a web journal as they have such significance for people travelling on short haul journeys. Issuing them via a web journal means the information is more quickly available to people travelling by air and can help them take precautions before they fly."

The study is still in progress. The interim findings are to be published in a web-journal linked to the European Venous Forum and can be found at www.venousforum-europe.org.

The full results of the study, once it is completed, will also be published in the web journal.Professor Gianni Belcaro

Professor Gianni Belcaro is Professor of Angiology at Chieti University in Italy and director of the Irvine2 vascular laboratory (department of biomedical sciences at G D'Annunzio University).

He is a Fellow of the Italian Society of Cardiovascular Surgery, the International College of Angiology and the Royal Society of Medicine (London).

Professor Belcaro is President of the Italian Society for Vascular Investigations and the author of more than 400 scientific articles and original papers.

anticoagulation@ntlworld.com

Copyright AntiCoagulation Europe 2006
Registered Charity No 1090250

Text too small? Click here.

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP | Tel: 020 8289 6875


PLEASE NOTE THIS WEBSITE SHOULD NOT BE USED TO REPLACE ADVICE FROM YOUR DOCTOR


We welcome feedback about our website. Please email your comments to
anticoagulation@ntlworld.com

 

Contact us by email

 

Contact us by post, phone or fax

 

What is atrial fibrillation?

 

About Cardioversion

 

ABout Ablation

 

Lionel

 

TIPS TO HELP YOU AVOID A DVT

 

TRAVELLER'S THROMBOSIS

 

Stress and heart disease

 

Medical Alert identity Card

 

MARIANNE GILL

 

John Kelman

 

MICHAEL KNIGHT

 

Evelyn Richardson

 

Max Crompton

 

1. Introduction

 

2. Overview

 

3. How to Roll out a near-patient testing service in Primary care

 

4. The importance of quality control and assurance and Selecting a POC device

 

5. Rolling out a Patient self-testing service

 

6. The patient's perspective

 

7. A personal account

 

8. Conclusion

 

Breaking News

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

A guide to setting up Near Patient Testing in Primary Care

 

NICE guidelines for atrial fibrillation

 

Near patient Testing in Tayside

 

Patients capable of self-testing: a systematic review

 

Breaking News

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

NICE guidance on Venous Thromboembolism (VTE)

 

Venous thromboembolism CMO press release

 

Front Line in Stroke Prevention - Report

 

New hope for early detection of deep vein thrombosis

 

NICE guidelines for atrial fibrillation

 

Ongoing trials for new oral anticoagulant

 

Expert pharmacists get the go-ahead

 

Patients capable of self-testing: a systematic review

 

News archive

 

'Strips on prescription' resource pack

 

Abolition of prescription charges

 

Equality for the Republic of Ireland

 

It's about time

 

It's about time survey

 

conference for health care professionals: Improving patient Safety and Managing Risks Associated with Anticoagulation Therapy

 

Conference 2008

 

Flora London MArathon 2008

 

CoaguNation Bus Tour

 

Roche Diagnostics launches CoaguNation Club

 

INR Test Monitors

 

Breaking news